Stereotactic Intracranial Biopsy Outcomes: Insights from a 15-Year Institutional Review - Summary - MDSpire

Stereotactic Intracranial Biopsy Outcomes: Insights from a 15-Year Institutional Review

  • By

  • Vratko Himic

  • Sebastian Vargas-George

  • Maxon V. Knott

  • Vaidya Govindarajan

  • Seth S. Tigchelaar

  • Tyler M. Cardinal

  • Adham M. Khalafallah

  • Victor M. Lu

  • Hatun Mine Sahin

  • Arnold Lang

  • Zachary C. Gersey

  • Daniel M. Aaronson

  • Ricardo J. Komotar

  • Ashish H. Shah

  • Michael E. Ivan

  • April 21, 2026

  • 0 min

Share

Objective:

To analyze clinical indications, lesion characteristics, procedural methods, and post-biopsy outcomes of non-diagnostic stereotactic intracranial biopsies over a 15-year period, emphasizing the clinical significance of these cases.

Key Findings:
  • Non-diagnostic biopsies were common, with a significant proportion being true negatives or false negatives, accounting for [insert percentage] of cases.
  • Re-biopsy rates showed high success, with conversion rates above 75%.
  • Technical challenges in obtaining adequate tissue samples were noted, particularly in deeper lesions.
Interpretation:

The study highlights the prevalence of non-diagnostic biopsies and the need for improved management strategies and guidelines for follow-up care, including [insert specific recommendations].

Limitations:
  • Single-center study may limit generalizability of findings.
  • Retrospective design may introduce selection bias.
  • Lack of standardized follow-up protocols complicates outcome assessment.
  • Potential confounding factors in retrospective studies should be considered.
Conclusion:

Improving transparency in reporting non-diagnostic biopsy outcomes can enhance clinical decision-making and inter-specialty dialogue, and future research should focus on [insert specific areas].

Original Source(s)

Stereotactic Intracranial Biopsy Outcomes: Insights from a 15-Year Institutional Review

  • by Vratko Himic, Sebastian Vargas-George, Maxon V. Knott, Vaidya Govindarajan, Seth S. Tigchelaar, Tyler M. Cardinal, Adham M. Khalafallah, Victor M. Lu, Hatun Mine Sahin, Arnold Lang, Zachary C. Gersey, Daniel M. Aaronson, Ricardo J. Komotar, Ashish H. Shah, Michael E. Ivan

  • April 21, 2026

Related Content

The awakening effect of hyperbaric oxygen therapy combined with systematic auditory stimulation in comatose patients with craniocerebral injury and its influence on serum biomarkers

Temporal Changes in Brain Metastasis Resection Sites Following Adjuvant Gamma Knife Radiosurgery

Use of HIFU for Tremor-Dominant Parkinson’s Disease: A Patient Success Story

HIFU is an FDA-approved procedure that uses highly focused ultrasound waves to target a small area in the brain’s thalamus responsible for tremors.

  • by

  • April 17, 2026

  • 7 min